Market Introduction
Liquid biopsy is a revolutionary technology that is opening up various perspectives. The technology consists of isolation and detection of circulating tumor cells, circulating tumor DNA and exosomes, which provides genomic information of the cancer patients. Liquid biopsy are used in cancer diagnosis in order to study response or resistance to given treatments.
Moreover, the European Society for Medical Oncology (ESMO) is the leading professional organization for medical oncology, is continuing to help oncology professionals by helping them to deliver optimal care to their cancer patients in such situations. The impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. However, due to growing COVID-19, the supply of diagnostics kits and assays are delayed because of growing quarantine time and shutting down all business operations. Europe is facing the massive impact of an outbreak due to exponential growth of infections in the region. As per data published by public sources, till March 26, Europe had an estimated 250,000 number of infected patients in the region. The outbreak badly hits countries such as Italy, Spain, Germany, France, and the UK.
Market Overview and Dynamics
The Europe liquid biopsy market is expected to reach US$ 2,251.12 Mn in 2027 from US$ 1,017.60 Mn in 2018. The market is anticipated to grow with a CAGR of 9.5% from 2019-2027. Factors driving the market growth include government and global health organizations initiatives. However, low sensitivity of liquid biopsy is likely to have a negative impact on market growth.
Key Market Segments
By product & services, the reagents and kits segment accounted for the largest market share in the Europen liquid biopsy market in 2018. In terms of sample, the blood based segment held the largest market share of the liquid biopsy market by 2027. By circulating biomarker, the circulating tumor cells (CTC) segment accounted for the largest market share in the Europen liquid biopsy market in 2019. By 2027, the oncology segment accounted for the largest market share by application. Furthermore, in terms of end user, the reference laboratories segment held the largest market share of the liquid biopsy market by 2027.
Major Sources and Companies Listed
Some of the major primary and secondary sources for liquid biopsy market included in the report are, Biotechnology and Biological Sciences Research Council (BBSRC), British Journal of Surgery (BJS), Cancer Center Amsterdam (CCA), International Diabetes Federation (IDF), and among others.
Reasons to buy the report
EUROPE LIQUID BIOPSY MARKET SEGMENTATION
By Product & Service
By Sample
By Circulating Biomarker
By Application
By End User
By Geography
• Europe
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 1,017.60 Million |
| Market Size by 2027 | US$ 2,251.12 Million |
| CAGR (2019 - 2027) | 9.5% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product & Services
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Liquid Biopsy Market is valued at US$ 1,017.60 Million in 2018, it is projected to reach US$ 2,251.12 Million by 2027.
As per our report Europe Liquid Biopsy Market, the market size is valued at US$ 1,017.60 Million in 2018, projecting it to reach US$ 2,251.12 Million by 2027. This translates to a CAGR of approximately 9.5% during the forecast period.
The Europe Liquid Biopsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Liquid Biopsy Market report:
The Europe Liquid Biopsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Liquid Biopsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Liquid Biopsy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Liquid Biopsy Market
